PubMed=19754820; DOI=10.1111/j.1476-5810.2006.00098.x
Uyama R., Nakagawa T., Hong S.-H., Mochizuki M., Nishimura R., Sasaki N.
Establishment of four pairs of canine mammary tumour cell lines derived from primary and metastatic origin and their E-cadherin expression.
Vet. Comp. Oncol. 4:104-113(2006)

PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001
Yoshitake R., Saeki K., Watanabe M., Nakaoka N., Ong S.M., Hanafusa M., Choisunirachon N., Fujita N., Nishimura R., Nakagawa T.
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Vet. J. 221:38-47(2017)

PubMed=33461558; DOI=10.1186/s12917-020-02709-5; PMCID=PMC7814552
Levi M., Salaroli R., Parenti F., De Maria R., Zannoni A., Bernardini C., Gola C., Brocco A., Marangio A., Benazzi C., Muscatello L.V., Brunetti B., Forni M., Sarli G.
Doxorubicin treatment modulates chemoresistance and affects the cell cycle in two canine mammary tumour cell lines.
BMC Vet. Res. 17:30.1-30.15(2021)